However, the difference between lymphoma patients with and without known CNS disease was also statistically significant, indicating that in patients with known CNS lymphoma diagnosis, CSF AT III concentrations were higher (p = 0.006). This evidence concerns the gene SERPINC1 and primary central nervous system lymphoma.